The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide

Published:2017-04 Issue: Volume:55 Page:71-82
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Del Re Marzia,Fogli Stefano,Derosa Lisa,Massari Francesco,De Souza Paul,Crucitta Stefania,Bracarda Sergio,Santini Daniele,Danesi Romano

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference172 articles.

1. Characterization of Phase I and Phase II hepatic drug metabolism activities in a panel of human liver preparations;Iyer;Chem Biol Interact,1999

2. Ontogeny of human conjugating enzymes;Coughtrie;Drug Metab Lett,2015

3. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation;Zanger;Pharmacol Ther,2013

4. Molecular mechanisms of the microsomal mixed function oxidases and biological and pathological implications;Cederbaum;Redox Biol.,2015

5. Selection of alternative CYP3A4 probe substrates for clinical drug interaction studies using in vitro data and in vivo simulation;Foti;Drug Metab Dispos,2010

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concomitant Administration of Psychotropic and Prostate Cancer Drugs: A Pharmacoepidemiologic Study Using Drug–Drug Interaction Databases;Biomedicines;2024-09-01

2. DoE-assisted HPLC method development and validation of enzalutamide and repaglinide in rat plasma;Bioanalysis;2024-08-08

3. Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments;Critical Reviews in Oncology/Hematology;2024-08

4. The association between polypharmacy and health-related quality of life among older adults with prostate cancer;Journal of Geriatric Oncology;2024-06

5. Drug–drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitors;Expert Review of Anticancer Therapy;2024-03-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3